Use of Antioxidant Nutrients in the Prevention and Treatment of Type 2 Diabetes

Journal of the American College of Nutrition

Volumn 20, Issue , 2001, Pages 363S-369S

  Ruhe, Rodney C ^a   McDonald, Roger B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lipoic acid; Non insulin dependent diabetes mellitus (NIDDM); Obesity; Oxidative damage; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; THIOCTIC ACID;

BODY WEIGHT; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIETARY INTAKE; GLUCOSE METABOLISM; HUMAN; INCIDENCE; MICROVASCULARIZATION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT; OBESITY; OXIDATION; PHYSICAL ACTIVITY; PROPHYLAXIS; RISK FACTOR; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ANTIOXIDANTS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DEVELOPED COUNTRIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; EXERCISE; HUMANS; INCIDENCE; OBESITY; OXIDATIVE STRESS; THIOCTIC ACID; VITAMIN E;

EID: 0034795929     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2001.10719169     Document Type: Article

References (44)

1. World Health Organization: “The World Health Report 1998. Life in the 21st Century a Vision for All.” Geneva: World Health Organization, 1998.
2. King H, Aubert RE, Herman WH: Global burden of diabetes 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care 21: 1414-1431, 1998.
3. Kenny SJ, Aubert RE, Geiss L: Prevalence and incidence of non-insulin-dependent diabetes. In: Harris MI (ed): “Diabetes in America” 2nd ed. Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases NIH publication, pp 47-67, 1995.
4. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23: 1278-1283, 2000.
5. Ruhe RC, McDonald RB: Carbohydrate metabolism and aging. In Watson RR: “Handbook of Nutrition in the Aged,” 3rd ed. Boca Raton: CRC Press, pp 205-237, 2000.
6. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960. Int J Obes 22: 39-47, 1998.
7. Kelly GS: Insulin resistance: lifestyle and nutritional interventions. Alter Med Rev 5: 109-32, 2000.
8. Wannamethee SG, Shaper AG: Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22: 1266-1272, 1999.
9. Heath GW, Gavin JR, Hinderliter JM, Hagberg JM, Bloomfield SA, Holloszy JO: Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity. J Appl Physiol 55: 512-517, 1983.
10. Seidell JC: Time trends in obesity: an epidemiological perspective. Horm Metab Res 21: 155-158, 1998.
11. Resnick HE, Valsania P, Halter JB, Lin X: Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidem Comm Health 54: 596-602, 2000.
12. Cox JH, Cortright RN, Dohm GL, Houmard JA: Effect of aging on response to exercise training in humans: skeletal muscle GLUT4 and insulin sensitivity. J Appl Physiol 86: 2019-2025, 1999.
13. Dengel PS, Pratley RE, Hagberg JM, Rogus EM, Goldberg AP: Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 81: 318-325, 1996.
14. Hsueh WA, Law RE: Cardiovascular risk continuum: Implications of insulin resistance and diabetes. Am J Med 105: 4S-14S, 1998.
15. Kawamori R: Asymptomatic hyperglycaemia and early atherosclerotic changes. Diabetes Res Clin Prac 40 (Suppl): 35S-42S, 1998.
16. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240, 1999.
17. Fedele D, Giugliano D: Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management. Drugs 54: 414-421, 1997.
18. Watts GF, Playford DA: Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 141: 17-30, 1998.
19. Diwadkar VA, Anderson JW, Bridges SR, Gowri MS, Oelgten PR: Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. Proc Soc Exp Biol Med 222: 178-184, 1999.
20. Paolisso G, Esposito R, D’Alessio MA, Barbieri M: Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab 25: 298-306, 1999.
21. Kanety H, Hemi R, Paz K, Karasik A: Cellular stress impairs insulin signaling (Abstract). Diabetol. 41(Suppl): A34, 1998.
22. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M: Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406, 1999.
23. Mosinger BJ: Higher cholesterol in human LDL is associated with the increase of oxidation susceptibility and the decrease of antioxidant defense: experimental and simulation data. Biochim Biophys Acta 1453: 180-184, 1999.
24. Renier G, Desfaits AC, Serri O: Effect of gliclazide on monocyteendothelium interactions in diabetes. J Diabetes Compl 14: 215-223, 2000.
25. Renier G, Desfaits, AC, Serri O: Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium. Metabolism 49: 17-22, 2000.
26. Cao G, Booth SL, Sadowski JA, Prior RL: Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruits and vegetables. Am J Clin Nutr 68: 1081-1087, 1998.
27. Cao G, Russell RM, Lischner N, Prior RL: Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr 128: 2383-2390, 1998.
28. Salonen JT, Nyyssonen K, Tuomainen T-P, Maenpaa PH, Korpela H, Kaplan GA, Lynch LJ, Helmrich SP, Salonen R: Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow-up study in men. Br J Med 311: 1124-1127, 1995.
29. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y: Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932, 1999.
30. Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, Kuroe A, Iwakura T, Kubota, A, Hiai H, Seino Y: Antiooxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett. 473: 24-26, 2000.
31. Laight DW, Desai KM, Gopaul NK, Anggard EE, Carrier MJ: F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur J Pharmacol 377: 89-92, 1999.
32. Laight DW, Desai KM, Gopaul NK, Anggard EE, Carrier MJ: Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat. Br J Pharmacol 128: 269-271, 1999.
33. Rimm EB, Stampfer MJ, Ascherio A, Giovanniucci E, Colditz GA, Willet WC: Vitamin E consumption and the risk of coronary heart disease in men. N Eng J Med 328: 1450-1456, 1993.
34. Sen CK, Roy S, Packer L: Alpha-lipoic acid: cell regulatory function and potential therapeutic implications. In Packer L, Hiramatsu M, Yoshikawa T (eds): “Antioxidant Food Supplements in Human Health.” New York: Academic, pp 111-119, 1999.
35. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K: Oral administration of RACalpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Radical Biol & Med 27: 309-314, 1999.
36. Ziegler D, Gries FA: Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 36 (Suppl 2): 62S-66S, 1997.
37. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schutte K, Gries FA: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetol 38: 1425-1433, 1995.
38. Ziegler D, Schatz H, Conrad F, Greis FA, Ulrich H, Reichel G: Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie [see comments]. Diabetes Care 20: 369-373, 1997.
39. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerum G, Malessa R: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22: 1296-1301, 1999.
40. Zeigler D, Reljanovid M, Mehnert H, Gries FA: Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrin Diabet 107: 421-430, 1999.
41. Lean ME, Noroozu M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A: Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48: 176-181, 1999.
42. Ford ES, Will JC, Bowman BA, Narayan KM: Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidem 149: 168-176, 1999.
43. Trachtman H, Futterweit S, Maneska J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH, Fu M-X, Baynes J: Taurine ameliorates chronic streptozocin-induced diabetes nephropathy in rats. Am J Physiol 269 (Renal, Fluid Electrolyte Physiol 38): F429-F438, 1995.
44. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS: Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 13: 203-208, 1999.